This is a comparison of intensity, not of technology. Clear + Brilliant is run at the low-intensity end of the fractional resurfacing range. Morpheus8 sits near the aggressive end of the energy-device range. Putting them side by side is like comparing a light weekly workout with a short block of hard training — both are exercise, but they are not alternatives in any simple sense.
Clear + Brilliant is a non-ablative fractional laser, run at low intensity. Non-ablative means it heats the skin without removing the surface. Fractional means it works in tiny columns with untreated skin in between, which is what keeps recovery short. It is designed to be repeated, and it is usually sold as a series with maintenance afterwards. It has not been placed against other fractional lasers on any measured scale, so treat "gentle" as a description of how it is used rather than a ranking.
Morpheus8 is microneedling with heat. Fine needles carry 1 MHz radiofrequency energy into the deeper layer of skin and release it from the tips, which are coated except for the last 0.5 mm. Needle depth is set by the operator — a fixed 0.5 mm resurfacing tip at one end, and up to 7 mm on the largest tips.
Doing less is the point of Clear + Brilliant, not a failing of it. A treatment that keeps you presentable and can be repeated on a schedule is a different product from one that asks for a marked week and delivers a slow change over months. The mistake is not choosing the gentler treatment. The mistake is expecting the gentler treatment to do the deeper one's job, or paying deeper-treatment prices for it.
The same family of technology as stronger resurfacing lasers, run at a much lower setting.
The untreated skin left between the columns is what makes recovery quick.
Because the pins are coated except at the tip, the heat is delivered below the surface rather than at the entry point.
What can be said is that it is the low-intensity option in this family of lasers.
Those figures come from InMode's operator manuals; 7 mm is also the highest depth in any FDA document for the device.
This is not a claim that it lacks one. Ask the clinic which clearance they are relying on, and for what.
The wording is electrocoagulation and hemostasis — surgical language for sealing tissue and stopping bleeding — from December 2019 (K192695), then coagulation or contraction of soft tissue from July 2023 (K231790).
No published study reports a recovery time for it, so no figure is quoted here.
In published studies of radiofrequency microneedling, redness occurred in every patient and swelling in about 30 per cent. One study put downtime at three to four days; another found skin barrier function back to normal by day seven.
Published protocols cluster at three sessions, three to eight weeks apart — a convention carried between studies rather than a tested dose.
There is a real asymmetry on this page, and it is worth naming. No clearance wording, no published treatment depth and no published recovery figure could be identified for Clear + Brilliant. Rather than fill those gaps with plausible numbers, this page leaves them open. That is not a criticism of the treatment — it means the specific questions below are worth putting to whoever is treating you:
There is also no reliable published price for Clear + Brilliant, and no professional society publishes one. For Morpheus8, the only dated figure available is crowdsourced: an average of $1,861 from 124 self-reported patient prices on RealSelf, last updated in May 2024, with single small-area sessions from $549. Treat that as one brand's self-reported number, not a survey.
Almost no published study used a Morpheus8. A PubMed search for the brand returns 16 records and no randomised controlled trial. The evidence supporting radiofrequency microneedling was generated on other machines — Lutronic Genius and Infini, Jeisys, Pollogen, Lumenis and several unnamed devices. The class evidence is genuine; it is just not this brand's.
And it stops at six months. That is the longest properly measured follow-up anywhere in this literature. Improvement was still holding at that point in the studies that measured it, which is a real finding — but "one to three years", which appears constantly in clinic copy, has no published source at all.
The FDA's voluntary postmarket database, analysed for radiofrequency microneedling across 2013 to 2025, held 114 reports containing 224 events, most often textural changes (56), pigment change (41) and loss of fat under the skin (26). Those are proportions of complaints with no denominator behind them, so they cannot be read as your odds. Against the fat-loss reports, a 30-person study that measured the fat layer under the chin by ultrasound found it unchanged while the skin above it thickened.
If you get cold sores, say so when you book, not on the day. Antiviral medicine is started in advance, so it has to be prescribed before the appointment. There is no published data on cold-sore reactivation after radiofrequency microneedling specifically; the practice is carried over from laser resurfacing, where reactivation is well documented and prophylaxis is standard.
Tell the clinic about a pacemaker or an implantable defibrillator, and about any metal implant near the treatment area, before booking Morpheus8. These are labelled contraindications for radiofrequency devices, and they are precautionary rather than tested. Your cardiology team is the right group to advise you.
If your skin tone is deeper, ask what energy per pin is planned for Morpheus8. Its clearance states that above 62 mJ per pin the applicator is limited to skin types I to IV, so higher settings in deeper phototypes sit outside the cleared labelling.